CRINETICS PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • May 3rd, 2018 • Crinetics Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is entered into as of February 9, 2018 by and among CRINETICS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and the investors listed on Exhibit A hereto (collectively referred to hereinafter as the “Investors” and each individually as an “Investor”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 3rd, 2018 • Crinetics Pharmaceuticals, Inc. • Pharmaceutical preparations • California
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between Crinetics Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and R. Scott Struthers (“Executive”), and shall be effective as of October 30, 2015 (the “Effective Date”).
LEASE AGREEMENT BETWEEN 6262 LUSK INVESTORS LLC, a California limited liability company (LANDLORD) AND CRINETICS PHARMACEUTICALS, INC., a Delaware corporation (TENANT) February 21, 2018 10222 Barnes Canyon Road SAN DIEGO, CALIFORNIALease Agreement • May 3rd, 2018 • Crinetics Pharmaceuticals, Inc. • Pharmaceutical preparations • California
THIS LEASE AGREEMENT (this “Lease”) is made as of February 21, 2018 (“Effective Date”), by and between 6262 LUSK INVESTORS LLC, a California limited liability company (“Landlord”), and CRINETICS PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
